Abstract: Substance use disorders are associated with substantial morbidity and mortality, including deaths due to drug overdose. In 2016, 63,632 individuals in the United States died of drug overdose, which brought the total number of drug overdose deaths between 1999 and 2016 to 632,331. Since the majority of drug overdoses involve opioids, a key component of the public health response to the opioid epidemic has been to increase access to evidence-based treatments for opioid use disorder.
This activity is only available to AJP CME subscribers.
Don't have a subscription to AJP CME? Subscribe Now!
- AJP Subscriber – 12 Month CME Subscription: $155.00
- Non AJP Subscriber – 12 Month CME Subscription: $310.00
If you have questions about AJP CME subscriptions, please contact firstname.lastname@example.org.
The participant will summarize how overdose deaths affect mental health care practitioners and identify methods that may be useful for clinicians and health systems to respond to overdose deaths.
This program is designed for all psychiatrists in clinical practice, residents in Graduate Medical Education programs, medical students interested in psychiatry, and other physicians who wish to advance their current knowledge of clinical medicine.
Estimated Time to Complete
Duration: 1 hour
Begin Date: March 1, 2019
End Date: February 28, 2021
How to Earn Credit
In order to earn CME credit, subscribers should read through the material presented in the article. After reading the article, complete the quiz and submit your evaluation and study hours (up to 1 AMA PRA Category 1 Credit™). A score of 60% or higher is required to receive credit.
The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The APA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Faculty and Planner Disclosures
Title: Supporting Providers After Drug Overdose Death
Authors: Amy M. Yule, M.D., Frances R. Levin, M.D.
Affiliations: Pediatric Psychopharmacology Program, Division of Child Psychiatry, Massachusetts General Hospital, and Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston (A.M.Y.); New York State Psychiatric Institute, Division of Substance Abuse, and Department of Psychiatry, College of Physicians and Surgeons of Columbia University, New York (F.R.L.).
Disclosures: Dr. Yule has received grant support from the Massachusetts General Hospital Louis V. Gerstner III Research Scholar Award; she receives funding through the American Academy of Child and Adolescent Psychiatry Physician Scientist Program in Substance Abuse (5K12DA000357-17); and she has served as a consultant for Phoenix House and the Gavin House (clinical service). Dr. Levin has served as a consultant for Major and Minor League Baseball.
Discussion of unapproved or investigational use of products*: No.
*APA policy requires disclosure by CME authors of unapproved or investigational use of products discussed in CME programs. Off-label use of medications by individual physicians is permitted and common. Decisions about off-label use can be guided by scientific literature and clinical experience.
Ned H. Kalin, M.D. (Editor-in-Chief, AJP); Michael D. Roy (Editorial Director, AJP); Michael A. Pogachar (Online Content Manager, Journals).
Dr. Kalin has received research support from NIH and NIMH; has served as a consultant for APA, CME Outfitters, the Pritzker Neuropsychiatric Disorders Research Consortium, the Skyland Trail Advisory Board, and TC MSO; owns stock in Seattle Genetics; and received honoraria from Elsevier as co-editor of the journal Psychoneuroendocrinology. Mr. Roy and Mr. Pogachar report no financial relationships with commercial interests.
Optimal System Configuration:
- Flash Player: Adobe Flash Player 10.1+
- Browser: Firefox 3+, Internet Explorer 8.0+, Safari 4.0+, or Google Chrome 7.0+
- Operating System: Windows XP+ or Mac OS X 10.4+
- Internet Connection: 1 Mbps or higher
- Screen Resolution: 1024 x 768 pixels.
- Windows PC:500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Sound Card at least 16-bit; Macromedia Flash Player 10 or higher, audio playback with speakers for programs with video content; Firefox 1.1+, Internet Explorer 7.0+, Safari 1.0+, Google Chrome, or Opera
- Macintosh: Mac OS X 10.3 or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit
For assistance: Contact email@example.com for questions about this course | Contact firstname.lastname@example.org for technical assistance